{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:05:22Z","timestamp":1795089922963,"version":"4.10.2"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>Mesonephric carcinomas of the gynecologic tract are neoplasms that are often under-recognized due to their varied morphologic appearances. Recently, GATA3 and TTF1 have been reported to be useful immunohistochemical markers for distinguishing mesonephric carcinomas from its morphologic mimics. Herein, we compared the performance of GATA3 and TTF1 to the traditional markers used for mesonephric carcinomas, CD10 and calretinin. We studied 694 cases: 8 mesonephric carcinomas (7 cervical [includes 3 mesonephric carcinosarcomas], 1 vaginal), 5 mesonephric-like carcinomas (4 uterine corpus, 1 ovarian), 585 endometrial adenocarcinomas, and 96 cervical adenocarcinomas. Mesonephric-like carcinomas were defined as tumors exhibiting the classic morphologic features of mesonephric carcinoma, but occurring outside of the cervix and without convincing mesonephric remnants. GATA3 had the highest sensitivity and specificity (91% and 94%) compared with TTF1 (45% and 99%), CD10 (73% and 83%), and calretinin (36% and 89%). GATA3, however, also stained a substantial number of uterine carcinosarcomas (23\/113, 20%). TTF1 was positive in 5\/5 (100%) mesonephric-like carcinomas and only 1\/8 (13%) mesonephric carcinomas. In 4\/6 (67%) TTF1 positive cases, GATA3 exhibited an inverse staining pattern with TTF1. In summary, GATA3 was the best overall marker for mesonephric and mesonephric-like carcinomas, but cannot be used to distinguish mesonephric carcinosarcomas from M\u00fcllerian carcinosarcomas. The inverse staining pattern between GATA3 and TTF1, suggests that TTF1 may be useful when GATA3 is negative in small biopsies where mesonephric or mesonephric-like carcinoma is suspected. The greater TTF1 positivity in mesonephric-like carcinomas suggests they may be biologically different from prototypical mesonephric carcinomas.<\/jats:p>","DOI":"10.1097\/pas.0000000000001142","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T21:26:48Z","timestamp":1535146008000},"page":"1596-1606","source":"Crossref","is-referenced-by-count":167,"title":["A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract"],"prefix":"10.1097","volume":"42","author":[{"given":"Jennifer","family":"Pors","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cheng","sequence":"additional","affiliation":[{"name":"Genetic Pathology Evaluation Center, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Leo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Royal Jubilee Hospital, Victoria, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Kinloch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saskatoon City Hospital, Saskatoon, SK, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"},{"name":"Genetic Pathology Evaluation Center, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia"},{"name":"Genetic Pathology Evaluation Center, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma","volume":"157","author":"Pirog","year":"2000","journal-title":"Am J Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2559.2010.03632.x","article-title":"p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection","volume":"57","author":"Houghton","year":"2010","journal-title":"Histopathology"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases","volume":"28","author":"Bagu\u00e9","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-\u03b2","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3","volume":"33","author":"Roma","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20230922","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","author":"Na","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PGP.0b013e318166067f","article-title":"Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature","volume":"27","author":"Wani","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","article-title":"Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases","volume":"14","author":"Ferry","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/00000478-200112000-00011","article-title":"Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation","volume":"25","author":"Ordi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000478-200302000-00005","article-title":"CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors","volume":"27","author":"Ordi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/his.12681","article-title":"GATA3 expression in gestational trophoblastic tissues and tumours","volume":"67","author":"Mirkovic","year":"2015","journal-title":"Histopathology"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAI.0b013e31825439bc","article-title":"Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update","volume":"20","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","article-title":"International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/PGP.0b013e31829ff239","article-title":"Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas","volume":"33","author":"Hoang","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1066896915611489","article-title":"Mesonephric adenocarcinoma of the uterine corpus: a case report and diagnostic pitfall","volume":"24","author":"Kim","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13000-017-0655-y","article-title":"Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review","volume":"12","author":"Ando","year":"2017","journal-title":"Diagn Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr.01.2012.5632","article-title":"Mesonephric adenocarcinoma of the uterine cervix and literature review","volume":"2012","author":"Anagnostopoulos","year":"2012","journal-title":"BMJ Case Rep"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ijgc-00009577-200605000-00079","article-title":"Second case of uterine mesonephric adenocarcinoma","volume":"16","author":"Marquette","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1373\/clinchem.2013.205740","article-title":"The emerging genomic landscape of endometrial cancer","volume":"60","author":"Le Gallo","year":"2014","journal-title":"Clin Chem"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0000000000000306","article-title":"Mixed mesonephric adenocarcinoma and high-grade neuroendocrine carcinoma of the uterine cervix: case description of a previously unreported entity with insights into its molecular pathogenesis","volume":"36","author":"Cavalcanti","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a M\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma","volume":"43","author":"McCluggage","year":"2013","journal-title":"Histopathology"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas","volume":"31","author":"Siami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201812000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:34:28Z","timestamp":1695422068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201812000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001142","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}